Pten knockout affects drug resistance differently in melanoma and kidney cancer.
Klaudia K BrodaczewskaAleksandra MajewskaAleksandra Filipiak-DulibanClaudine KiedaPublished in: Pharmacological reports : PR (2023)
The results confirmed heterogenous cell responses to PTEN loss, which may lead to a better understanding of the role of PTEN in particular types of tumors and points to PTEN as a therapeutic target for personalized medicine.